Allen, et al., “Mucus Glycoprotein Structure, Gel Formation and Gastrointestinal Mucus Function” in J. Nugent & M. O'Connor, Eds., Mucus and Mucosa, Ciba Foundation Symposium 109, Pitman, London, 1984, pp. 137. |
Beck ,et al., “A new long-acting injectable microcapsule system for the administration of progesterone,” Fertil. Steril. 31(5):545-51 (1979). |
Benita, et al., “Characterization of drug-loaded poly(d,l-lactide) microspheres,” J. Pharm. Sci. 73(12):1721-24 (1984). |
Duchene, et al., “Pharmaceutical and medical aspects of bioadhesive systems for drug administration,” Drug Dev. Ind. Pharm. 14:283-318 (1988). |
Edelman, et al., “Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition,” Proc. Natl. Acad. Sci. U. S. A. 90(4):1513-17 (1993). |
Furia, CRC Handbook of Food Additives, Cleveland, OH 1968. |
Gurny, et al., “Bioadhesive intraoral release systems: design, testing and analysis,” Biomaterials 5(6):336-40 (1984). |
Harada, et al., “Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts,” J. Clin. Invest. 94(2):623-30 (1994). |
Horowitz & Pigman, The Glycoconjugates, pp. 560 (New York: Academic Press, Inc., 1977). |
Horowitz, “Mucopolysaccharides and Glycoproteins of the Alimentary Tract” in Alimentary Canal (eds. C. F. Code), pp. 1063-85 (Washington: American Physiological Society, 1967). |
Labat-Robert & Decaeus, “Glycoproteins du mucus gastrique: Structure fonctions et pathologie et biologie,” Pathologie et Biologie (Paris) 24:241 (1979). |
Labhasetwar, et al., “Sotalol controlled-release systems for arrhythmias: In vitro characterization, in Vivi drug disposition and electrophysilogic effects,” J. Pharm. Sci. 83:156-64 (1994). |
Lee, et al., “Design of oral patches for the treatment of aphthous stomatitis: drug layer”, Yakche Hakhoechi 25(4):339-45 (1995). |
Lehr, et al., “Intestinal transit of bioadhesive microspheres in an in situ Loop in the rat-A comparative study with copolymers and blends based on poly(acrylic) acid,” J. Controlled Rel. Soc. 13:51-62 (1990). |
Mathiowitz, et al., “Morphology of polyanhydride microsphere delivery systems,” Scanning Microsc. 4(2):329-40 (1990). |
Mathiowitz, et al., “Novel microcapsules for delivery systems,” Reactive Polymers 6:275-83 (1987). |
Mikos, et al., “Interaction of polymer microspheres with mucin gels as a means of characterizing polymer retention on mucus,” J. Colloid Interface Sci. 143:366-73 (1991). |
Park, et al., “Alternative Approaches to Oral Controlled Drug Delivery: Bioadhesives and In-Situ Systems,” in Anderson & Kim, eds., “Recent Advances in Drug Delivery,” pp. 163-83, (Plenum Press, New York 1984). |
Pigman & Gottschalk, “Submaxillary Gland Glycoproteins” in Glycoproteins: Their Composition, Structure and Function (eds. A. Gottschalk), pp. 434-45 (Amsterdam: Elsevier Publishing Company, Inc., 1966). |
Scawen & Allen, “The action of proteolytic enzymes on the glycoprotein from pig gastric mucus,” Biochem. J. 163(2):363-68 (1977). |
Smart, et al., “An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery,” J. Pharm. Pharmacol. 36(5):295-99 (1984). |
Spiro, “Glycoproteins,” Annu. Rev. Biochem. 39:599-638 (1970). |
Tutwiler, et al., “A pharmacologic profile of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N′-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective hypoglycemic agent,” Diabetes 27(8):856-67 (1978). |